Prof Allan Kermode

Prof Allan Kermode is a Neurologist (Brain Specialist) based in Subiaco, Australia. He obtained his Bachelor of Medicine and Bachelor of Surgery degrees in 1985 and went on to complete his Doctor of Medicine in 1991. Prof Kermode also holds a PhD in the field.

With over three decades of experience in the medical field, Prof Kermode is a highly regarded specialist in the diagnosis and management of neurological conditions. He has a particular interest in Multiple Sclerosis, a chronic disease affecting the central nervous system.

Prof Kermode is a Fellow of the Royal Australasian College of Physicians, having completed his fellowship in 1992. He is also a member of the Royal College of Physicians in the UK, which further signifies his dedication to excellence in his field.

Throughout his career, Prof Kermode has been actively involved in research and medical education. He has published numerous articles in reputable medical journals and has been invited to speak at national and international conferences.

As a compassionate healthcare professional, Prof Kermode strives to provide the highest level of care to his patients. He adopts a patient-centered approach, taking the time to listen to their concerns and develop personalized treatment plans. His expertise in neurology combined with his excellent communication skills has earned him the trust and respect of his patients and colleagues alike.

Prof Allan Kermode's commitment to advancing the field of neurology is evident in his continuous involvement in teaching and mentoring medical students and young doctors. His passion for education translates into exceptional patient care as he remains up-to-date with the latest advancements and treatment options in neurology.

With his extensive knowledge, experience, and dedication to his profession, Prof Allan Kermode is a trusted and valued member of the medical community. His patients can rest assured that they are in capable hands when seeking his expertise in the management of neurological conditions, particularly in the field of Multiple Sclerosis.